TNF and nasopharyngeal carcinoma: Since NPC1 patients could be particularly vulnerable to adverse neurological events due to their underlying progressive neurological disease we investigated if anti-TNF is a safe and effective treatment strategy for intestinal inflammation in NPC patients.